Estate Counselors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,000
| Closed | -$28.9K | – | 130 |
|
|
2023
Q4 | $28.9K | Hold |
17,000
| – | – | ﹤0.01% | 118 |
|
|
2023
Q3 | $17.5K | Hold |
17,000
| – | – | ﹤0.01% | 124 |
|
|
2023
Q2 | $19.7K | Buy |
+17,000
| New | +$19.7K | ﹤0.01% | 124 |
|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$12K | – | 159 |
|
|
2022
Q3 | $12K | Hold |
3,000
| – | – | ﹤0.01% | 160 |
|
|
2022
Q2 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 162 |
|
|
2022
Q1 | $17K | Hold |
3,000
| – | – | ﹤0.01% | 159 |
|
|
2021
Q4 | $27K | Hold |
3,000
| – | – | ﹤0.01% | 161 |
|
|
2021
Q3 | $32K | Hold |
3,000
| – | – | ﹤0.01% | 169 |
|
|
2021
Q2 | $46K | Hold |
3,000
| – | – | 0.01% | 161 |
|
|
2021
Q1 | $49K | Buy |
+3,000
| New | +$49K | 0.01% | 157 |
|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$44K | – | 130 |
|
|
2020
Q2 | $44K | Buy |
+3,000
| New | +$44K | 0.01% | 143 |
|